Concepedia

Virginia Albiñana

VA

16

Publications

497

Citations

12

H-Index

2008

Active since

Affiliations

Centro de Investigaciones Biológicas Margarita Salas(Current)

Centro de Investigación Biomédica en Red

Centre for Biomedical Network Research on Rare Diseases

Hospital Universitario Fundación Jiménez Díaz

Instituto de Salud Carlos III

Virginia Albiñana is an author at Centro de Investigaciones Biológicas Margarita Salas specializing in molecular signaling, medicine, and immunology.

Top concepts

Publications per year

2008–2022

16

Publications

16

Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells

Virginia Albiñana, Maria Bernabeu-Herrero, Roberto Zarrabeitia et al. · Thrombosis and Haemostasis · 2010 · 83 citations

Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia

Virginia Albiñana, Lucía Recio-Poveda, Roberto Zarrabeitia et al. · Thrombosis and Haemostasis · 2012 · 57 citations

Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor-β1 Signaling in Endothelial Cells

Virginia Albiñana, Francisco Sanz‐Rodríguez, Lucía Recio-Poveda et al. · Molecular Pharmacology · 2011 · 56 citations

Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients

Virginia Albiñana, Karina Villar Gómez de las Heras, Gemma Serrano‐Heras et al. · Orphanet Journal of Rare Diseases · 2015 · 51 citations · Full text

Mutation study of Spanish patients with Hereditary Hemorrhagic Telangiectasia

Ana Fontalba, Africa Fernández-L, Eva García‐Alegría et al. · BMC Medical Genetics · 2008 · 37 citations · Full text

Rows per page

1–5 of 16